Disclosure 0001836067-26-000010-1

SEC FORM 4

$0.00

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Acquisition (code M) of 750 shares at $0 per share.

Reporting Person Rubin Jonathan · Officer Title SVP, Chief Medical Officer · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001836067-26-000010 · filed 2026-08-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "SUPERNUS PHARMACEUTICALS, INC. (SUPN)." Disclosed 2026-08-14. https://desqlong.com/cards/0001836067-26-000010-1 (retrieved 2026-09-26).